## AMPX: Amprius Technologies, Inc. - XLI: Industrials

### Executive Summary

No clear thesis: MRS_10 at 3.6%, does not meet entry criteria. Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($9.70)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Geode Capital Management LLC Increases Stock Holdings in Amprius Technologies, Inc. $AMPX**
- Source: MarketBeat | 20251207T051203 | Neutral | Relevance: 97%
-  Geode Capital Management LLC significantly increased its stake in Amprius Technologies (NYSE:AMPX) by 167.9% in Q2, acquiring 1,593,607 shares valued at $6.71 million. This increase occurred despite recent insider share sales by the CTO and CEO, totaling over $1.1 million, and the company has received a "Moderate Buy" consensus rating from analysts with an average target price of $14.29. Amprius also reported strong Q3 earnings, beating EPS and revenue estimates.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.20M) |
| Sells | 2 ($0.94M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 25.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Blackrock Inc.: 5.7% (+41.5%)
- Vanguard Group Inc: 5.0% (+37.0%)
- Driehaus Capital Man: 2.4% (+100.0%)
- Morgan Stanley: 2.1% (+41.9%)
- Citadel Advisors Llc: 1.9% (+796.4%)

### Key Risks

1. High beta (2.96) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Elevated short interest (13.0%): bears positioning against stock.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Momentum building: MRS_10 improving +4.6% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.58 indicates undervaluation relative to growth. Balance sheet: strong liquidity (6.7x). Revenue growth strong at 71% YoY. Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $1.5B |
| Beta | 2.96 |
| 52W Range | $1.63 - $16.03 |
| Short Interest | 13.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.58 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_10 strengthening from -1.0% to 3.6% (+4.6% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 84th percentile. MRS_5 at 0.5% confirms short-term momentum alignment. Outperforming sector by 4.3pp, stock-specific strength. RSI neutral at 52.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.61% (CS: 85) | Strong |
| RSI_14 | 52.0 | Neutral |
| MACD Histogram | 0.15 | Bullish |
| vs SMA20 | 1.039x | Above |
| vs SMA50 | 0.980x | Below |
| vs SMA200 | 1.785x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $11.80
- **Stop Loss:** $9.70 (17.8% risk)
- **Target:** $13.90 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 238
- **Position Value:** $2,808.40
- **Portfolio %:** 2.81%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-03-19 (Est: $-0.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.06 | $-0.03 | +47.8% |
| 2025Q2 | $-0.08 | $-0.05 | +37.5% |
| 2025Q1 | $-0.09 | $-0.08 | +11.1% |
| 2024Q4 | $-0.10 | $-0.09 | +16.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*